Archer Aviation Stock Steadies After Short-Seller Report

Archer Aviation (ACHR) stock stabilized around $10.66 on May 29 after an initial 12-14% drop following a short-seller report from Culper Research on May 20 alleging misleading progress claims. While institutional filings showed increased investment in Archer prior to the report, investor focus has shifted to the company's ability to execute upcoming operational milestones, including UAE deployment, manufacturing goals, and FAA certification, to counter the short-seller's claims; analysts have a 12-month price target of $12.50, but other stocks may be better buys.

Analysis

Archer Aviation's stock (NYSE: ACHR), priced at $10.59 as of May 29, 2025, has demonstrated recent stabilization around $10.66 following an initial 12-14% decline triggered by a Culper Research short-seller report on May 20th. This report questioned Archer's Midnight eVTOL testing timelines and a key flight milestone, allegations the company dismissed as "baseless." The market's subsequent behavior suggests it has largely absorbed these claims, with investor focus now shifting critically towards Archer's ability to deliver on upcoming operational milestones. These include the planned summer 2025 deployment of its first piloted Midnight aircraft to the UAE, aiming for revenue generation later in the year, a 2025 manufacturing target of up to ten aircraft, and continued progress towards FAA Type Certification targeted for late 2025. Reinforcing Archer's fundamental position are Q4 2024 institutional filings indicating increased holdings by major investors before the report surfaced, and strong Q1 2025 financial results which featured an earnings per share beat and a confirmed cash position exceeding $1 billion. Current analyst consensus reflects a "Moderate Buy" rating with an average 12-month price target of $12.50, indicating cautious optimism heavily reliant on the company's successful execution of its operational and certification targets.

Key Decisions for Investors

• Investors should closely monitor Archer's execution of its near-term operational milestones, particularly the UAE deployment, manufacturing ramp-up, and FAA certification progress, as these will be pivotal in validating the company's capabilities against the short-seller's allegations.
• Consider the company's robust Q1 2025 financial health, including a cash balance exceeding $1 billion and prior institutional accumulation, as positive fundamental signals, but weigh these against the inherent execution risks and speculative nature of the pre-commercial eVTOL sector.
• Evaluate the potential upside indicated by the $12.50 average analyst price target in the context of upcoming catalysts, while also noting that successful milestone achievement is critical to de-risking the investment and that Archer was not listed among some top analysts' immediate buy recommendations, warranting a thorough risk assessment.